WAM
CMRAW

Wolverine Asset Management’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Wolverine Asset Management’s Portfolio CMRAW Stock Details CMRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,637
Closed -$317 – 2120
2023
Q3 		$317 Hold
14,637
– – ﹤0.01% 1780
2023
Q2 		$396 Hold
14,637
– – ﹤0.01% 1695
2023
Q1 		$630 Sell
14,637
-1,058
-7% -$52 ﹤0.01% 1743
2022
Q4 		$748 Hold
15,695
– – ﹤0.01% 1962
2022
Q3 		$0 Hold
15,695
– – ﹤0.01% 2631
2022
Q2 		$2K Buy
+15,695
New +$2.57K ﹤0.01% 2242

Other funds holding CMRAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Wolverine Asset Management's CMRAW Position: Q4 2023 in Review

Wolverine Asset Management sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q4 2023, closing a stake of 14,637 shares — an estimated $317 sold.

Wolverine Asset Management first reported a position in CMRAW in Q2 2022 and held it in 6 quarters. The position peaked at $2K in Q2 2022. 3 funds tracked by Wall St. Rank hold CMRAW as of Q4 2023.

  • Wolverine Asset Management reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q4 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 14,637 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q4 2023, an estimated $317.
  • Wolverine Asset Management first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 6 quarters.
  • Wolverine Asset Management's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $2K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q4 2023.

Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.